Cannara Biotech Inc. (LOVFF)

Cannara Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 23, 2024	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	44	45	67	91	118	54
Market Cap Growth	-32.08%	-32.08%	-26.24%	-23.18%	119.59%	-34.84%
Enterprise Value	73	78	97	112	127	57
Last Close Price	0.48	0.54	0.75	1.00	1.30	0.75
PE Ratio	9.18	9.51	13.02	51.35	-	-
PS Ratio	0.75	0.75	1.58	3.30	8.75	27.48
PB Ratio	0.70	0.70	1.13	1.77	2.32	1.83
P/TBV Ratio	0.70	0.70	1.13	1.77	2.32	1.83
P/FCF Ratio	19.05	19.05	-	-	-	-
P/OCF Ratio	5.73	5.73	15.29	-	-	-
EV/Sales Ratio	1.28	1.28	2.29	4.07	9.40	29.09
EV/EBITDA Ratio	7.48	7.62	7.92	16.91	58.11	-
EV/EBIT Ratio	13.70	13.69	11.17	30.25	3041.18	-
EV/FCF Ratio	30.56	32.55	-	-	-	-
Debt / Equity Ratio	0.55	0.55	0.57	0.73	0.33	0.34
Debt / EBITDA Ratio	3.45	3.45	2.75	5.54	7.15	-
Debt / FCF Ratio	15.04	15.04	-	-	-	-
Asset Turnover	0.55	0.55	0.43	0.33	0.23	0.04
Inventory Turnover	1.41	1.41	1.14	1.40	1.39	1.09
Quick Ratio	0.73	0.73	0.70	1.75	1.63	2.32
Current Ratio	2.50	2.50	2.44	3.46	2.82	3.03
Return on Equity (ROE)	7.68%	7.68%	9.48%	3.52%	-2.98%	-29.66%
Return on Assets (ROA)	3.22%	3.22%	5.48%	2.77%	0.04%	-12.16%
Return on Capital (ROIC)	3.65%	3.65%	6.09%	3.01%	0.05%	-13.06%
Earnings Yield	10.52%	10.52%	7.68%	1.95%	-1.03%	-17.81%
FCF Yield	5.25%	5.25%	-4.39%	-18.20%	-22.26%	-26.41%
Buyback Yield / Dilution	-1.83%	-1.83%	-2.16%	-14.80%	-7.26%	-16.02%
Total Shareholder Return	-1.83%	-1.83%	-2.16%	-14.80%	-7.26%	-16.02%

Source: S&P Capital IQ. Standard template. Financial Sources.